A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Clinical trial NCT06948461 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06948461
Sponsor: PharmaPlanter Technologies Inc
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)Irritable Bowel Syndrome (IBS)Clostridioides Difficile Infection

Start date: 2025-09-01
Primary completion: 2026-09-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.